Peripheral Stem Cell Transplantation Plus Chemotherapy in Treating Patients With Malignant Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Ovarian Cancer
Related studies linked through entity extraction aliases.
Immunotoxin Therapy in Treating Patients With Advanced Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Capecitabine in Treating Patients With Recurrent Ovarian Epithelial or Primary Peritoneal Cavity Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Paclitaxel Plus Carboplatin With or Without Topotecan in Treating Patients With Stage IIB, Stage III, or Stage IV Ovarian Epithelial Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Carboplatin With or Without Gemcitabine in Treating Patients With Advanced Ovarian Epithelial Cancer That Has Not Responded to Previous Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE3
Oxaliplatin and Topotecan in Treating Patients With Previously Treated Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
- Status
- COMPLETED
- Phase
- PHASE1
STI571 in Treating Patients With Recurrent or Refractory Soft Tissue Sarcoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Chemotherapy With or Without Surgery in Treating Patients With Recurrent Ovarian Cancer
- Status
- TERMINATED
- Phase
- PHASE3
Nitrocamptothecin in Treating Patients With Recurrent or Metastatic Ovarian Epithelial or Primary Peritoneal Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
Rebeccamycin Analogue in Treating Patients With Refractory Stage III or Stage IV Ovarian Epithelial Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Liposomal Doxorubicin and Carboplatin in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Nitrocamptothecin in Treating Patients With Advanced Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE2
SU5416 and Carboplatin to Treat Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Monoclonal Antibody Therapy in Treating Patients Scheduled for Surgery to Remove Ovarian Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Temozolomide in Treating Patients With Metastatic Germ Cell Tumors That Have Not Responded to Cisplatin
- Status
- COMPLETED
- Phase
- PHASE2
Vaccine Therapy in Treating Patients With Ovarian, Fallopian Tube, or Peritoneal Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Liposomal Lurtotecan Plus Cisplatin in Treating Patients With Advanced or Metastatic Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Gemcitabine Plus Cisplatin in Treating Patients With Ovarian Epithelial Cancer or Primary Peritoneal Cancer That Is Recurrent or Has Not Responded to Platinum-based Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE2
Biological Therapy in Treating Patients With Advanced Cancer
- Status
- COMPLETED
- Phase
- NA
Temozolomide Plus Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Malignant Glioma or Recurrent CNS or Other Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2